{
  "id": "Tisdale_risk_score_for_QT_prolongation.v3",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2021-01-27",
      "name": "Penina Adhiambo Ogendo, Neha Tiwari",
      "organisation": "KI Health Informatics Students",
      "email": "penogendo@yahoo.com"
    },
    "lifecycle_state": "Not set",
    "details": {
      "en": {
        "id": "en",
        "purpose": "To predict the risk of QT prolongation greater than 500 msec in hospitalized patients.",
        "keywords": [
          "QT prolongation",
          "Torsade de pointes (TDP)",
          "Electrocardiography",
          "Predictors",
          "Risk Factors"
        ],
        "use": "This simple score can estimate risk of QT prolongation for a physician or pharmacist managing a patient in the hospital.\n\nWhy use\nQT interval prolongation increases the risk of Torsade de pointes (TdP), a type of polymorphic ventricular tachycardia which is life-threatening and often fatal.",
        "misuse": "There are many known factors that increase the risk of QT prolongation; the ones included in this score were found to be the most predictive, but others should not be ignored. Some of the other common risks include:\n\nOther electrolyte abnormalities like hypomagnesemia or hypocalcemia\n\nInadequate dose adjustment for patients with acute or chronic kidney dysfunction\n\nDrug-drug interactions\n\nCredibleMeds.org provides an outstanding comprehensive list of clinical risk factors for QT prolongation. \n\nCredibleMeds.org also provides a comprehensive list of drugs that may cause QT prolongation.\n\nDrug-drug interactions should always be considered when prescribing multiple medications; this score does not include pharmacokinetic drug interactions.\n\nThis score also does not consider dosing adjustments for renally-eliminated drugs.\n\nClinicians should always try to avoid QT-prolonging medications when possible.\n\nMaintaining normal electrolyte levels can help reduce the risk of QT prolongation as well.\n\nPatients with very poor ejection fractions (<20%) are particularly high risk for QT prolongation.",
        "copyright": "@Cambio2021"
      }
    },
    "other_details": {
      "references": "References:\n1. Tisdale JE, Jaynes HA, Kingery JR, et al. Development and validation of a risk score to predict QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes. 2013;6(4):479-87.\n2. Tisdale JE, Jaynes HA, Kingery JR, Overholser BR, Mourad NA, Trujillo TN, Kovacs RJ. Effectiveness of a clinical decision support system for reducing the risk of QT interval prolongation in hospitalized patients. Circ Cardiovasc Qual Outcomes 2014;7:381-390.\n3.Tisdale JE. Drug-induced QT interval prolongation and torsades de pointes: Role of the pharmacist in risk assessment, prevention and management. Can Pharm J (Ott). 2016;149(3):139-52."
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.tisdale_risk_score_for_qt_prolongation.v0",
        "template_id": "openEHR-EHR-OBSERVATION.tisdale_risk_score_for_qt_prolongation.v0",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0016]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0019]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0022]"
          },
          "gt0006": {
            "id": "gt0006",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0024]"
          },
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0029]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0033]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0037]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0042]"
          },
          "gt0011": {
            "id": "gt0011",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0047]"
          }
        }
      },
      "gt0012": {
        "id": "gt0012",
        "model_id": "openEHR-EHR-EVALUATION.tisdale_risk_score_for_qt_prolongation.v0",
        "template_id": "openEHR-EHR-EVALUATION.tisdale_risk_score_for_qt_prolongation.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0013": {
            "id": "gt0013",
            "path": "/data[at0001]/items[at0002]"
          }
        }
      },
      "gt0014": {
        "id": "gt0014",
        "model_id": "openEHR-EHR-OBSERVATION.tisdale_risk_score_for_qt_prolongation.v0",
        "template_id": "openEHR-EHR-OBSERVATION.tisdale_risk_score_for_qt_prolongation.v0",
        "type": "OUTPUT",
        "elements": {
          "gt0015": {
            "id": "gt0015",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0055]"
          }
        }
      }
    },
    "rules": {
      "gt0016": {
        "id": "gt0016",
        "priority": 4,
        "when": [
          "$gt0003|Age 68 years|!=null",
          "$gt0004|Sex|!=null",
          "$gt0005|Patient on loop diuretic|!=null",
          "$gt0006|Potassium 3.5 mEq/L|!=null",
          "$gt0007|Admission QTc 450 msec|!=null",
          "$gt0008|Being admitted for acute myocardial infarction|!=null",
          "$gt0009|Being admitted for sepsis|!=null",
          "$gt0010|Being admitted for heart failure|!=null",
          "$gt0011|Number of QTc-prolonging drugs given|!=null"
        ],
        "then": [
          "$gt0015|Tisdale Risk Score|.magnitude=$gt0003.value+$gt0004.value+$gt0005.value+$gt0006.value+$gt0007.value+$gt0008.value+$gt0009.value+$gt0010.value+$gt0011.value"
        ]
      },
      "gt0017": {
        "id": "gt0017",
        "priority": 3,
        "when": [
          "$gt0015|Tisdale Risk Score|<=6"
        ],
        "then": [
          "$gt0013|Interpretation|=0|local::at0003|Low - Always consider that higher risk may develop depending on clinical course and drug interactions and pharmacokinetics.|"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 2,
        "when": [
          "$gt0015|Tisdale Risk Score|>=7"
        ],
        "then": [
          "$gt0013|Interpretation|=1|local::at0004|Moderate - Consider consultation with pharmacist, adjusting risk factors as much as possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc. |"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 1,
        "when": [
          "$gt0015|Tisdale Risk Score|>11"
        ],
        "then": [
          "$gt0013|Interpretation|=2|local::at0005|High - Consider consultation with pharmacist, adjusting risk factors as much as possible, and using alternative medications if possible. EKG should be repeated after 5 half-lives of QT-prolonging drugs given to evaluate QTc.|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "Tisdale risk score for qt prolongation",
            "description": "Prediction on risk of QT prolongation in hospitalized patients."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Age 68 years",
            "description": "*"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Sex",
            "description": "*"
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Patient on loop diuretic",
            "description": "*"
          },
          "gt0006": {
            "id": "gt0006",
            "text": "Potassium 3.5 mEq/L",
            "description": "*"
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Admission QTc 450 msec",
            "description": "*"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Being admitted for acute myocardial infarction",
            "description": "*"
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Being admitted for sepsis",
            "description": "*"
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Being admitted for heart failure",
            "description": "*"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Number of QTc-prolonging drugs given",
            "description": "*"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Interpretation",
            "description": "*"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Tisdale Risk Score",
            "description": "*"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Tisdale Risk Score"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Rule 1"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Rule 2"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Rule 3"
          }
        }
      }
    }
  }
}